Literature DB >> 8442240

Is retransplantation cost effective?

R W Evans1, D L Manninen, F B Dong, D A McLynne.   

Abstract

Mesh：

Year:  1993        PMID： 8442240

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

1.  Can we direct organ allocation based on predicted outcome? Hepatocellular carcinoma outside of UCSF criteria or retransplant?

Authors:  Caroline Rochon; Patricia Sheiner; Basant Mahadevappa; Ganesh Gunasekaran; Joyti Sharma; David C Wolf; Marcelo Facciuto
Journal:  Langenbecks Arch Surg       Date:  2012-01-28       Impact factor: 3.445

Review 2.  Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.

Authors:  J E Frampton; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

Review 3.  Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.

Authors:  R Whittington; K L Goa
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

4.  Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization.

Authors:  W R Kim; R H Wiesner; J J Poterucha; T M Therneau; M Malinchoc; J T Benson; J S Crippin; G B Klintmalm; J Rakela; T E Starzl; R A Krom; R W Evans; E R Dickson
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

Review 5.  Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.

Authors:  A J Coukell; G L Plosker
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

6.  Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation.

Authors:  Kenneth Siu Ho Chok; Albert C Y Chan; James Y Y Fung; Wing Chiu Dai; Tan To Cheung; Chung Mau Lo
Journal:  Hepatol Int       Date:  2017-09-21       Impact factor: 6.047

7.  Decision for retransplantation of the liver: an experience- and cost-based analysis.

Authors:  Daniel Azoulay; Marcello M Linhares; Emmanuel Huguet; Valérie Delvart; Denis Castaing; René Adam; Philippe Ichai; Faouzi Saliba; Antoinette Lemoine; Didier Samuel; Henri Bismuth
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

8.  Long-term survival after retransplantation of the liver.

Authors:  J F Markmann; J S Markowitz; H Yersiz; M Morrisey; D G Farmer; D A Farmer; J Goss; R Ghobrial; S V McDiarmid; R Stribling; P Martin; L I Goldstein; P Seu; C Shackleton; R W Busuttil
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

9.  Health-related quality of life following liver transplantation.

Authors:  S Bryan; J Ratcliffe; J M Neuberger; A K Burroughs; B K Gunson; M J Buxton
Journal:  Qual Life Res       Date:  1998-02       Impact factor: 4.147

10.  Hepatic Retransplantation--an analysis of risk factors associated with outcome.

Authors:  H R Doyle; F Morelli; J McMichael; C Doria; L Aldrighetti; T E Starzl; I R Marino
Journal:  Transplantation       Date:  1996-05-27       Impact factor: 4.939
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.